Warwick Scientists Unearth New Antibiotic to Combat Superbugs Like MRSA

Scientists from the University of Warwick and Monash University have discovered a new antibiotic, pre-methylenomycin C lactone, that shows promise against drug-resistant bacteria like Methicillin-resistant Staphylococcus aureus (MRSA).

• The compound, pre-methylenomycin C lactone, is over 100 times more effective than its parent antibiotic, methylenomycin A, highlighting its potential in combating antimicrobial resistance.
• Collaboration between the University of Warwick and Monash University led to the discovery, emphasizing the importance of international research in addressing drug resistance.
• The research is particularly significant for treating infections caused by Vancomycin-resistant Enterococcus and Methicillin-resistant Staphylococcus aureus, both of which pose severe health risks.